The main challenge of non-viral gene delivery is the design of effective and non-cytotoxic vectors and tools capable of targeted delivery of genetic material to intended sites to alter cellular function and/or structure (Pezzoli et al., 2012).Since their introduction, chemical vectors - cationic carriers able to self-assemble with anionic nucleic acids (NAs) into particles (complexes) in order to overcome cellular barriers - and physical methods - the application of membrane-disruptive forces to ease the NAs intracellular delivery - have made strides forward (Mehier-Humbert and Guy, 2005; Tros de Ilarduya et al., 2010). However, the poor efficiency of the former and the risk of potential cell damage of the latter are hampering their widespr...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
Introduction: Non-viral vectors are cationic lipids or polymers that spontaneously assemble with nuc...
Gene delivery is the transfer of genetic material into recipient cells to alter some functions. As t...
The main challenge of non-viral gene delivery is the design of effective and non-cytotoxic vectors a...
INTRODUCTION: The major drawback in the use of non-viral means for gene delivery purposes stands in ...
Introduction Gene therapy is a promising strategy for the treatment of genetic disorders. In this c...
Introduction: Non-viral gene delivery employs positively charged lipidic or polymeric vectors to dri...
Purpose/Objectives: One major drawback of non-viral gene delivery means stands in the lack of suitab...
Background: With the success of recent non-viral gene delivery-based COVID-19 vaccines, nanovectors ...
Introduction Since their first introduction, non-viral vectors for gene delivery purposes have made...
Introduction Despite the recent success of COVID-19 vaccines, the use of non-viral carriers, namely...
Gene delivery is the transfer of genetic material into recipient cells to alter some functions. As t...
Introduction: Non-viral gene delivery strategies emerged as a new breakthrough for clinical and rese...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
Introduction: Non-viral vectors are cationic lipids or polymers that spontaneously assemble with nuc...
Gene delivery is the transfer of genetic material into recipient cells to alter some functions. As t...
The main challenge of non-viral gene delivery is the design of effective and non-cytotoxic vectors a...
INTRODUCTION: The major drawback in the use of non-viral means for gene delivery purposes stands in ...
Introduction Gene therapy is a promising strategy for the treatment of genetic disorders. In this c...
Introduction: Non-viral gene delivery employs positively charged lipidic or polymeric vectors to dri...
Purpose/Objectives: One major drawback of non-viral gene delivery means stands in the lack of suitab...
Background: With the success of recent non-viral gene delivery-based COVID-19 vaccines, nanovectors ...
Introduction Since their first introduction, non-viral vectors for gene delivery purposes have made...
Introduction Despite the recent success of COVID-19 vaccines, the use of non-viral carriers, namely...
Gene delivery is the transfer of genetic material into recipient cells to alter some functions. As t...
Introduction: Non-viral gene delivery strategies emerged as a new breakthrough for clinical and rese...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
Introduction: Non-viral vectors are cationic lipids or polymers that spontaneously assemble with nuc...
Gene delivery is the transfer of genetic material into recipient cells to alter some functions. As t...